FDA Approves Children's Claritin (loratadine) for Allergic Rhinitis Symptoms
FDA approves Children's Claritin chewable tablets for allergy relief in kids 2 and older.
The FDA approved Children's Claritin (loratadine) chewable tablets for temporary relief of hay fever or upper respiratory allergy symptoms i…
The FDA approved Children's Claritin (loratadine) chewable tablets for hay fever and allergy symptoms in children ages 2 and older. It treat…
FDA Approves Xyzal Allergy 24hr (levocetirizine) for Hay Fever and Respiratory Allergy Symptoms
FDA approves new over-the-counter allergy drug Xyzal Allergy 24hr
The FDA approved Xyzal Allergy 24hr (levocetirizine) for temporary relief of symptoms due to hay fever or other respiratory allergies, inclu…
The FDA approved Xyzal Allergy 24hr (levocetirizine) for temporary relief of hay fever and other allergy symptoms like runny nose, sneezing,…
Narrative review discusses colorectal cancer metastasis patterns with immune checkpoint inhibitors and targeted therapies
Liver metastasis linked to resistance in colorectal cancer treated with immune checkpoint inhibitors
This narrative review examines response patterns to immune checkpoint inhibitors, anti-angiogenic agents, and targeted therapies in colorect…
A review of colorectal cancer treatments suggests liver metastasis is linked to resistance against immune checkpoint inhibitors, while lung …
Narrative review examines metabolic syndrome and novel agents in kidney transplant recipients
Kidney transplant patients face high metabolic risks and rejection
This narrative review addresses antibody-mediated rejection and metabolic syndrome in kidney transplantation recipients. The authors note th…
About half of kidney transplant recipients develop metabolic problems within a year, while antibody-mediated rejection remains a major cause…
Review of alpha-gal syndrome highlights tick bite link and knowledge gaps
Tick bites may explain why some people develop alpha-gal allergy
This narrative review synthesizes evidence on alpha-gal syndrome, focusing on tick bites as a sensitizing exposure. The authors note that ep…
A review links tick bites to alpha-gal syndrome, though scientists still do not fully understand the biological mechanisms behind this react…
Systematic review and meta-analysis of resveratrol for spinal cord injury in animal models
Resveratrol shows promise for spinal cord injury in animal studies
This systematic review and meta-analysis of 38 preclinical animal studies found that resveratrol significantly improved locomotor recovery a…
A review of animal studies suggests resveratrol may improve movement and reduce damage after spinal cord injury, but human trials are needed…
Molecular review explores Siglec signaling pathways in cancer and inflammatory disorders
Siglec proteins help immune system balance fighting disease and avoiding self-harm
This molecular review examines the role of Siglec signaling pathways in human biology. The authors discuss potential therapeutic opportuniti…
Siglec proteins act as brakes on immune cells, and targeting them could help treat cancer and autoimmune disorders.
Narrative review highlights diagnostic gaps for house dust mite allergy in tropical regions
Understanding house dust mite allergy challenges in tropical regions for better patient care
This narrative review examines house dust mite allergy in populations living in tropical regions. The authors note that significant knowledg…
This review highlights how house dust mites cause allergies differently in tropical areas. Experts say current tools often miss these unique…
COPD guideline proposes cellular phenotype classification for targeted therapy
New framework shifts COPD care from symptom control to targeting disease drivers
This guideline review proposes classifying COPD by cellular phenotype to guide targeted therapies. It synthesizes evidence on neutrophilic, …
A new guideline offers a fresh way to treat chronic obstructive pulmonary disease by targeting specific disease drivers instead of just mana…
Living systematic review finds low-certainty evidence that stopping csDMARDs before surgery may increase flare risk in inflammatory arthritis
Stopping arthritis drugs before surgery may raise flare risk
This living systematic review evaluates perioperative management of conventional synthetic DMARDs in adults with rheumatoid arthritis, psori…
Low-certainty evidence suggests stopping certain arthritis drugs before surgery might increase the chance of a disease flare, but infection …
Meta-analysis of upadacitinib for rheumatoid arthritis finds similar efficacy for 15 mg and 30 mg doses
Upadacitinib improves rheumatoid arthritis symptoms in meta-analysis
This systematic review and meta-analysis of 5,237 participants with rheumatoid arthritis found that upadacitinib 15 mg and 30 mg significant…
A new analysis finds upadacitinib helps rheumatoid arthritis symptoms, but higher dose raises infection risk.
Narrative review discusses extracellular vesicles as biomarkers for cancer, neurological disorders, and cardiovascular diseases
Extracellular vesicles show promise as biomarkers for multiple diseases
This narrative review evaluates the potential of extracellular vesicles (EVs) as biomarkers for cancer, neurological disorders, and cardiova…
A review suggests extracellular vesicles could serve as useful biomarkers for cancer, neurological disorders, and cardiovascular diseases, t…